Diagnósticos da América S.A. (BVMF:DASA3)
Brazil · Delayed Price · Currency is BRL 2.650
-0.120 (-4.33%)
Jun 17, 2026, 5:05 PM GMT-3
Diagnósticos da América Market Cap
Diagnósticos da América has a market cap or net worth of 3.46 billion as of June 17, 2026. Its market cap has increased by 72.07% in one year.
Market Cap
3.46B
Enterprise Value
10.19B
Revenue
9.57B
Ranking
n/a
PE Ratio
n/a
Stock Price
2.65
Market Cap Chart
Since November 19, 2004, Diagnósticos da América's market cap has increased from 1.14B to 3.46B, an increase of 204.95%. That is a compound annual growth rate of 5.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 3.46B | -38.99% |
| Dec 30, 2025 | 5.67B | 299.54% |
| Dec 30, 2024 | 1.42B | -80.24% |
| Dec 28, 2023 | 7.19B | -6.51% |
| Dec 29, 2022 | 7.69B | -58.42% |
| Dec 30, 2021 | 18.49B | -46.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 74.95B |
| Bradsaúde | 38.44B |
| Raia Drogasil | 30.53B |
| Hypera | 15.12B |
| Fleury | 8.25B |
| Empreendimentos Pague Menos | 2.81B |
| Blau Farmacêutica | 2.29B |
| Dimed S.A. Distribuidora de Medicamentos | 1.69B |